Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.jiph.2020.08.001

http://scihub22266oqcxt.onion/10.1016/j.jiph.2020.08.001
suck pdf from google scholar
32888871!7442131!32888871
unlimited free pdf from europmc32888871    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32888871      J+Infect+Public+Health 2020 ; 13 (11): 1611-1618
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • From SARS to COVID-19: What lessons have we learned? #MMPMID32888871
  • Liu Q; Xu K; Wang X; Wang W
  • J Infect Public Health 2020[Nov]; 13 (11): 1611-1618 PMID32888871show ga
  • After the outbreak of severe acute respiratory syndrome (SARS) in November 2002, coronaviruses (CoVs) received worldwide attention. On December 1, 2019, the first case of coronavirus disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), was reported in Wuhan, China, and CoVs returned to public view. On January 30, 2020, the World Health Organization (WHO) declared that the COVID-19 epidemic is a public health emergency of international concern (PHEIC), and on March 11, 2020, the WHO classified COVID-19 as a pandemic disease. As of July 31, 2020, COVID-19 has affected 216 countries and regions, with 17,064,064 confirmed cases and 668,073 deaths, and the number of new cases has been increasing daily. Additionally, on March 19, 2020, there were no new confirmed cases in China, providing hope and valuable experience for the international community. In this review, we systematically compare COVID-19 and SARS in terms of epidemiology, pathogenesis and clinical characteristics and discuss the current treatment approaches, scientific advancements and Chinese experience in fighting the epidemic to combat the novel coronavirus pandemic. We also discuss the lessons that we have learned from COVID-19 and SARS.
  • |*Public Health[MESH]
  • |Betacoronavirus[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Vaccines[MESH]
  • |China/epidemiology[MESH]
  • |Clinical Trials as Topic[MESH]
  • |Coronavirus Infections/drug therapy/*epidemiology/immunology/prevention & control/transmission[MESH]
  • |Humans[MESH]
  • |Medicine, Chinese Traditional[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/drug therapy/*epidemiology/transmission[MESH]
  • |SARS-CoV-2[MESH]
  • |Severe Acute Respiratory Syndrome/drug therapy/*epidemiology/transmission[MESH]
  • |Severe acute respiratory syndrome-related coronavirus[MESH]
  • |Viral Vaccines/immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box